Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Akebia and GSK will grapple with heightened scrutiny of HIF PHIs after roxadustat concerns,

While FibroGen did not disclose details on the CRL’s contents, it did say that the agency requested an additional clinical study before the application …, While FibroGen did not disclose details on the CRL’s contents, it did say that the agency requested an additional clinical study before the application …, Read More

Scroll to Top